Slovenian Institute for Transfusion Medicine, Šlajmerjeva 6, Ljubljana, 1000, Slovenia.
Faculty of Medicine, University of Ljubljana, Korytkova ulica 2, Ljubljana, 1000, Slovenia.
J Transl Med. 2024 Jun 6;22(1):541. doi: 10.1186/s12967-024-05368-4.
Dendritic cells (DCs) have been intensively studied in correlation to tumor immunology and for the development DC-based cancer vaccines. Here, we present the significance of the temporal aspect of DC maturation for the most essential subsequent timepoint, namely at interaction with responding T cells or after CD40-Ligand restimulation. Mostly, DC maturation is still being achieved by activation processes which lasts 24 h to 48 h. We hypothesized this amount of time is excessive from a biological standpoint and could be the underlying cause for functional exhaustion. Indeed, shorter maturation periods resulted in extensive capacity of monocyte-derived DCs to produce inflammatory cytokines after re-stimulation with CD40-Ligand. This effect was most evident for the primary type 1 polarizing cytokine, IL-12p70. This capacity reached peak at 6 h and dropped sharply with longer exposure to initial maturation stimuli (up to 48 h). The 6 h maturation protocol reflected superiority in subsequent functionality tests. Namely, DCs displayed twice the allostimulatory capacity of 24 h- and 48 h-matured DCs. Similarly, type 1 T cell response measured by IFN-γ production was 3-fold higher when CD4 T cells had been stimulated with shortly matured DC and over 8-fold greater in case of CD8 T cells, compared to longer matured DCs. The extent of melanoma-specific CD8 cytotoxic T cell induction was also greater in case of 6 h DC maturation. The major limitation of the study is that it lacks in vivo evidence, which we aim to examine in the future. Our findings show an unexpectedly significant impact of temporal exposure to activation signals for subsequent DC functionality, which we believe can be readily integrated into existing knowledge on in vitro/ex vivo DC manipulation for various uses. We also believe this has important implications for DC vaccine design for future clinical trials.
树突状细胞 (DC) 在肿瘤免疫学研究和基于 DC 的癌症疫苗开发方面受到了广泛关注。在这里,我们介绍了 DC 成熟的时间方面对于最重要的后续时间点(即与反应性 T 细胞相互作用或在 CD40L 刺激后)的重要性。大多数情况下,DC 的成熟仍然是通过持续 24 至 48 小时的激活过程来实现的。我们假设从生物学角度来看,这段时间过长,可能是功能衰竭的根本原因。事实上,较短的成熟时间导致单核细胞来源的 DC 在再次用 CD40L 刺激后产生大量炎性细胞因子。对于主要的 1 型极化细胞因子 IL-12p70,这种效应最为明显。这种能力在 6 小时达到峰值,并随着初始成熟刺激时间的延长而急剧下降(最长可达 48 小时)。6 小时的成熟方案在后续功能测试中表现出优越性。即,6 小时成熟的 DC 的同种刺激能力是 24 小时和 48 小时成熟的 DC 的两倍。同样,当 CD4 T 细胞用短暂成熟的 DC 刺激时,产生 IFN-γ 的 1 型 T 细胞反应是用 24 小时和 48 小时成熟的 DC 刺激时的两倍,而在 CD8 T 细胞中,这种反应是用 24 小时和 48 小时成熟的 DC 刺激时的 8 倍以上。在 6 小时 DC 成熟的情况下,黑素瘤特异性 CD8 细胞毒性 T 细胞的诱导程度也更高。该研究的主要局限性在于缺乏体内证据,我们旨在未来进行检验。我们的研究结果表明,DC 随后的功能与暴露于激活信号的时间长短之间存在出乎意料的显著影响,我们相信这可以很容易地整合到现有的关于各种用途的体外/离体 DC 操作的知识中。我们还认为,这对未来临床试验中 DC 疫苗的设计具有重要意义。